Nexgel IncNASDAQ:NXGL
- LAST PRICE3.2890
- TODAY'S CHANGE (%)0.0190 (0.5810%)
- Bid / Lots3.2500/ 1
- Ask / Lots3.3000/ 1
- Open / Previous Close3.3100 / 3.2700
- Day Range
- 52 Week Range
- Volume16,400
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NXGL |
|---|---|---|
| 09:32 ET | 1152 | 3.31 |
| 09:33 ET | 3217 | 3.25 |
| 09:35 ET | 355 | 3.27 |
| 09:39 ET | 623 | 3.25 |
| 09:42 ET | 2500 | 3.3399 |
| 09:48 ET | 100 | 3.34 |
| 09:57 ET | 150 | 3.28 |
| 10:04 ET | 1281 | 3.34 |
| 10:06 ET | 238 | 3.3399 |
| 10:08 ET | 163 | 3.34 |
| 10:18 ET | 250 | 3.3146 |
| 10:24 ET | 1230 | 3.34 |
| 10:26 ET | 230 | 3.37 |
| 10:51 ET | 315 | 3.3236 |
| 11:07 ET | 900 | 3.33 |
| 11:09 ET | 412 | 3.27 |
| 11:43 ET | 1846 | 3.289 |
Yesterday
NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024, from 9:00AM ET on Thursday Nov 21, 2024 by Dow Jones
9:00AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 13, 2024
NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially, from 4:40PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:40PM ET on Wednesday Nov 13, 2024 by Dow Jones*DJ NexGel 3Q Rev $2.94M >NXGL, from 4:40PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:40PM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 11, 2024
NEXGEL Announces $2,000,000 Registered Direct Offering, from 5:35PM ET on Monday Nov 11, 2024 by Dow Jones
5:35PM ET on Monday Nov 11, 2024 by Dow JonesNEXGEL to Report Third Quarter 2024 Financial Results on November 13th, from 9:00AM ET on Monday Nov 11, 2024 by Dow Jones
9:00AM ET on Monday Nov 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nexgel Inc | 22.1M | -5.7x | --- |
Dare Bioscience Inc | 28.1M | -6.2x | --- |
BioXcel Therapeutics Inc | 23.2M | -0.2x | --- |
Cyclo Therapeutics Inc | 20.1M | -0.8x | --- |
China Health Industries Holdings Inc | 21.3M | -15.6x | --- |
Evoke Pharma Inc | 6.7M | -0.4x | --- |
Company Information
NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CG labs segment comprises the CG Converting and Packaging, LLC used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its hydrogel consumer products are marketed under the brand names MedaGel and LumaGel Beauty. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. It also specializes in eye and eyelash consumer products.
Contact Information
- Headquarters
- 2150 Cabot Boulevard West, Suite BLANGHORNE, PA, United States 19047
- Phone
- 215-702-8550
- Fax
- 302-636-5454
Executives
- President, Chief Executive Officer, Director
- Adam Levy
- Chief Financial Officer
- Adam Drapczuk
- Independent Director
- Steven Mark Glassman
- Independent Director
- Scott Henry
- Independent Director
- Nachum Stein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $22.1M |
|---|---|
Revenue (TTM) | $6.7M |
Shares Outstanding | 6.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.58 |
Book Value | $0.82 |
P/E Ratio | -5.7x |
Price/Sales (TTM) | 3.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -58.44% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
